These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

509 related articles for article (PubMed ID: 27568472)

  • 1. Effects of various gastrointestinal procedures on β-cell function in obesity and type 2 diabetes.
    Malin SK; Kashyap SR
    Surg Obes Relat Dis; 2016 Jul; 12(6):1213-9. PubMed ID: 27568472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EndoBarrier gastrointestinal liner. Delineation of underlying mechanisms and clinical effects.
    Rohde U
    Dan Med J; 2016 Nov; 63(11):. PubMed ID: 27808040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential Acute Impacts of Sleeve Gastrectomy, Roux-en-Y Gastric Bypass Surgery and Matched Caloric Restriction Diet on Insulin Secretion, Insulin Effectiveness and Non-Esterified Fatty Acid Levels Among Patients with Type 2 Diabetes.
    Thomas F; Smith GC; Lu J; Babor R; Booth M; Beban G; Chase JG; Murphy R
    Obes Surg; 2016 Aug; 26(8):1924-31. PubMed ID: 26729277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved glucose metabolism following bariatric surgery is associated with increased circulating bile acid concentrations and remodeling of the gut microbiome.
    Kaska L; Sledzinski T; Chomiczewska A; Dettlaff-Pokora A; Swierczynski J
    World J Gastroenterol; 2016 Oct; 22(39):8698-8719. PubMed ID: 27818587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute effects of gastric bypass versus gastric restrictive surgery on beta-cell function and insulinotropic hormones in severely obese patients with type 2 diabetes.
    Kashyap SR; Daud S; Kelly KR; Gastaldelli A; Win H; Brethauer S; Kirwan JP; Schauer PR
    Int J Obes (Lond); 2010 Mar; 34(3):462-71. PubMed ID: 20029383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bariatric surgery in patients with type 2 diabetes: benefits, risks, indications and perspectives.
    Scheen AJ; De Flines J; De Roover A; Paquot N
    Diabetes Metab; 2009 Dec; 35(6 Pt 2):537-43. PubMed ID: 20152741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in Weight Loss and Gut Hormones: Rouen-Y Gastric Bypass and Sleeve Gastrectomy Surgery.
    Malin SK; Kashyap SR
    Curr Obes Rep; 2015 Jun; 4(2):279-86. PubMed ID: 26627222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of improved glycaemic control after Roux-en-Y gastric bypass.
    Bojsen-Møller KN
    Dan Med J; 2015 Apr; 62(4):B5057. PubMed ID: 25872541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Roux-en-Y gastric bypass and sleeve gastrectomy: mechanisms of diabetes remission and role of gut hormones.
    Nannipieri M; Baldi S; Mari A; Colligiani D; Guarino D; Camastra S; Barsotti E; Berta R; Moriconi D; Bellini R; Anselmino M; Ferrannini E
    J Clin Endocrinol Metab; 2013 Nov; 98(11):4391-9. PubMed ID: 24057293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Updates in weight loss surgery and gastrointestinal peptides.
    Svane MS; Bojsen-Møller KN; Madsbad S; Holst JJ
    Curr Opin Endocrinol Diabetes Obes; 2015 Feb; 22(1):21-8. PubMed ID: 25517025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attenuated improvements in adiponectin and fat loss characterize type 2 diabetes non-remission status after bariatric surgery.
    Malin SK; Bena J; Abood B; Pothier CE; Bhatt DL; Nissen S; Brethauer SA; Schauer PR; Kirwan JP; Kashyap SR
    Diabetes Obes Metab; 2014 Dec; 16(12):1230-8. PubMed ID: 25132119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bile acids and bariatric surgery.
    Albaugh VL; Banan B; Ajouz H; Abumrad NN; Flynn CR
    Mol Aspects Med; 2017 Aug; 56():75-89. PubMed ID: 28390813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of early improvement/resolution of type 2 diabetes after bariatric surgery.
    Mingrone G; Castagneto-Gissey L
    Diabetes Metab; 2009 Dec; 35(6 Pt 2):518-23. PubMed ID: 20152737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin sensitivity and secretion modifications after bariatric surgery.
    Castagneto-Gissey L; Mingrone G
    J Endocrinol Invest; 2012 Jul; 35(7):692-8. PubMed ID: 22732257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in Bile Acid Metabolism, Transport, and Signaling as Central Drivers for Metabolic Improvements After Bariatric Surgery.
    Browning MG; Pessoa BM; Khoraki J; Campos GM
    Curr Obes Rep; 2019 Jun; 8(2):175-184. PubMed ID: 30847736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes of insulin sensitivity and secretion after bariatric/metabolic surgery.
    Mingrone G; Cummings DE
    Surg Obes Relat Dis; 2016 Jul; 12(6):1199-205. PubMed ID: 27568471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut feelings about diabetes.
    Laferrère B
    Endocrinol Nutr; 2012 Apr; 59(4):254-60. PubMed ID: 22386248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intestinal peptide changes after bariatric and minimally invasive surgery: Relation to diabetes remission.
    Castagneto Gissey L; Casella Mariolo J; Mingrone G
    Peptides; 2018 Feb; 100():114-122. PubMed ID: 29412812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetes and branched-chain amino acids: What is the link?
    Bloomgarden Z
    J Diabetes; 2018 May; 10(5):350-352. PubMed ID: 29369529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive Value of Gut Peptides in T2D Remission: Randomized Controlled Trial Comparing Metabolic Gastric Bypass, Sleeve Gastrectomy and Greater Curvature Plication.
    Casajoana A; Pujol J; Garcia A; Elvira J; Virgili N; de Oca FJ; Duran X; Fernández-Veledo S; Vendrell J; Vilarrasa N
    Obes Surg; 2017 Sep; 27(9):2235-2245. PubMed ID: 28451931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.